Literature DB >> 28791997

[Eosinophilic granuloma of the parietal bone of an adult patient with BRAF mutation].

O V Dolzhansky1, E M Paltseva1, A A Bukaeva1, E V Zaklyazminskaya1, I A Spivak2, D N Fedorov1.   

Abstract

The paper describes a case of eosinophilic granuloma of the parietal bone in a 32-year-old man. Histological examination revealed a large number of bean-shaped Langerhans cell histiocytes with lobed nuclei and nuclear grooves. The histiocytes alternated with the foci of obvious eosinophilic infiltration and with eosinophilic microabscesses. There were osteoclast-like multinucleated giant cells, bone resorption, and numerous bone rods covered with osteoblast chains. The histiocytes expressed CD1α, langerin, CD68, S100, and p53 (in 90.0% of the tumor cells). The Ki-67 proliferation index was 18.0%. A molecular genetic study identified BRAFV600E mutation (nucleotide substitution s.1799 T>A (p.V600E) in the heterozygous state). Clinical and morphological data and the results of molecular genetic studies led to the conclusion that there was eosinophilic granuloma of the right parietal bone (the unifocal form of Langerhans cell histiocytosis (LCH), type I, group A1, with the monoossal nature of lesion and with BRAFV600E mutation). In adults, this disease is extremely rare (2-5 cases of LCH per million people, bone loss in the fourth decade of life in 2.5% of the patients).

Entities:  

Keywords:  Langerhans cell histiocytosis; bone tissue; eosinophilic granuloma; immunohistochemistry; molecular genetics

Mesh:

Substances:

Year:  2017        PMID: 28791997     DOI: 10.17116/patol201779433-39

Source DB:  PubMed          Journal:  Arkh Patol        ISSN: 0004-1955


  1 in total

1.  A rapidly expanding calvarial Langerhans cell histiocytosis with low Ki-67 in an adult: a challenging diagnosis on magnetic resonance imaging.

Authors:  Mustafa Kemal Demir; Ozlem Yapıcıer; Teyyub Hasanov; Deniz Kilic; Turker Kilic
Journal:  Neuroradiol J       Date:  2017-11-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.